High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer

High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer

Abstract Adjuvant chemotherapy (ACT) is usually used to reduce the risk of disease relapse and improve survival for stage II/III colorectal cancer (CRC). However, only a subset of patients could benefit from ACT. Thus, there is an urgent need to identify improved biomarkers to predict survival and s...

Full description

Bibliographic Details
Main Authors: Shu-Biao Ye, Yi-Kan Cheng, Pei-Si Li, Lin Zhang, Lian-Hai Zhang, Yan Huang, Ping Chen, Yi Wang, Chao Wang, Jian-Hong Peng, Li-Shuo Shi, Li Ling, Xiao-Jian Wu, Jun Qin, Zi-Huan Yang, Ping Lan
Format: Article
Language:English
Published: Nature Portfolio 2023-05-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-023-00400-0

Internet

https://doi.org/10.1038/s41698-023-00400-0

Similar Items